GNVC previously reported that it has extended its research collaboration and license agreement with Novartis. Novartis, through its subsidiaries, engages in the research, development, manufacture, and marketing of healthcare products worldwide.
Under the extension, Novartis will fund research at GenVec through January 2013 to support its hearing loss and balance disorders program.
GNVC is a biopharmaceutical company using differentiated, proprietary technologies to create superior therapeutics and vaccines. A key component of our strategy is to develop and commercialize our product candidates through collaborations. GenVec is working with leading companies and organizations such as Novartis, Merial, and the U.S. Government to support a portfolio of product programs that address the prevention and treatment of a number of significant human and animal health concerns. GenVec’s development programs address therapeutic areas such as hearing loss and balance disorders; as well as vaccines against infectious diseases including respiratory syncytial virus (RSV), herpes simplex virus (HSV), dengue fever, influenza, malaria, and human immunodeficiency virus (HIV). In the area of animal health we are developing vaccines against foot-and-mouth disease (FMD).
For more information about GNVC please visit http://www.genvec.com
****
Honda Motor Co., Ltd (NYSE:HMC) released its seventh annual report on the environmental impact of the company’s operations in the North American region, including the United States, Canada and Mexico. The 2011 North American Environmental Report, published in electronic format only, can be viewed and downloaded here. Highlights of the 2011 North American Environmental Report include: Products – the CO2-adjusted fleet-average fuel economy of Honda and Acura automobiles sold in the U.S. in model year 2010 rose 1 mpg, or 4.1%, to 25.6 mpg, versus the previous model year. This compares with a U.S. auto industry average increase of 0.1 mpg, or 0.4%, during the same period. Further, the fleet average fuel economy of Honda motorcycles sold in North America in FY2011 was improved 12.0% from the FY2000 baseline.
Honda Motor Co., Ltd., together with its subsidiaries, engages in the development, manufacture, and distribution of motorcycles, automobiles, and power products primarily in North America, Europe, and Asia.
****
The J. M. Smucker Company (NYSE:SJM) declared a $0.48 per share dividend on the common shares of the Company to be paid on Thursday, March 1, 2012, to shareholders of record at the close of business on Friday, February 10, 2012. In other actions, the Board increased the Company’s share repurchase authorization by five million common shares. Future share repurchases will occur at management’s discretion and there is no guarantee as to the exact number of shares that may be repurchased. The Company has approximately two million common shares remaining for repurchase under its January 2011 Board authorization.
The J. M. Smucker Company engages in manufacturing and marketing branded food products in the United States, Canada, and internationally.
****
Lockheed Martin Corporation (NYSE:LMT) announced that its Board of Directors has authorized a first quarter 2012 dividend of $1 per share. The dividend is payable on March 23, 2012 to holders of record as of the close of business on March 1, 2012. Lockheed Martin has paid a dividend to shareholders every quarter since its inception in 1995. Headquartered in Bethesda, Md., Lockheed Martin is a global security company that employs about 123,000 people worldwide and is principally engaged in the research, design, development, manufacture, integration and sustainment of advanced technology systems, products and services. The Corporation’s net sales for 2011 were $46.5 billion. www.lockheedmartin.com.
Lockheed Martin Corporation engages in the research, design, development, manufacture, integration, operation, and sustainment of advanced technology systems and products in the areas of defense, space, intelligence, homeland security, and government information technology in the United States and internationally.
******************************************************************
For FREE Daily Stock Alerts & Updates Sign-up At: http://pennytobuck.com/signup
******************************************************************
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. PennyToBuck.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer (http://pennytobuck.com/disclaimer ) is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold PennyToBuck.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (CRWE.OB) is a media-advertisement and newswire company. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period.









